Researchers developed a saliva based SERS platform that detects epilepsy, Parkinson's disease, and schizophrenia by analyzing protein structural changes with up to 98% accuracy.

An app that essentially elevates coughing into a smartphone into a sophisticated diagnostic tool has performed well again in a clinical study. Australian digital health company ResApp, which makes a ...

TEL AVIV, Israel--(BUSINESS WIRE)--QuantHealth, an AI-powered clinical trial design company, announced it has surpassed 100 successfully simulated clinical trials, achieving 85 percent accuracy and ...